Company

Bristol Myers Squibb

5 briefings tracked

Bristol Myers Squibb is a major pharmaceutical company headquartered in New Jersey. The company has increasingly focused on using artificial intelligence to accelerate drug discovery and development, reflecting a broader industry trend toward AI-powered pharmaceutical research and innovation. Bristol Myers Squibb has deepened its strategic partnership with chipmaker Nvidia to build advanced computing systems specifically designed to support drug research operations. The company acquired Nvidia's latest-generation computing hardware, including the Vera Rubin system, to power its large-scale AI-driven drug discovery efforts. This significant commitment to state-of-the-art AI infrastructure underscores how leading pharmaceutical companies are adopting high-performance computing systems to streamline and accelerate the critical processes of identifying, developing, and bringing new medicines to market.

Latest on Bristol Myers Squibb